ArticleCancer research2017

Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.

Yi Ban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.